Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS safety_alert · 2026-04-08Clinical Trial Update: Vascular Toxicities of Immune ChecKpoint Inhibitors : From Bed to Benchside [NA]
A clinical trial update outlining vascular toxicities observed with immune checkpoint inhibitors, highlighting safety signals and implicatio…
-
EMA safety_alert · 2018-06-01EMA restricts use of Keytruda and Tecentriq in bladder cancer
The European Medicines Agency restricts the use of Keytruda (pembrolizumab) and Tecentriq (atezolizumab) for bladder cancer due to concerns …
-
EMA safety_alert · 2011-10-21European Medicines Agency clarifies opinion on pioglitazone and the risk of bladder cancer
The EMA clarifies its opinion regarding pioglitazone and the risk of bladder cancer, addressing safety concerns and regulatory stance.
-
EMA safety_alert · 2011-07-21European Medicines Agency recommends new contra-indications and warnings for pioglitazone to reduce small increased risk of bladder cancer
EMA recommends new contraindications and warnings for pioglitazone to address a small increased risk of bladder cancer.